Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: January 17, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Dolastatin 10

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the development status for investigational drug Dolastatin 10?

Dolastatin 10 is an investigational drug.

There have been 7 clinical trials for Dolastatin 10. The most recent clinical trial was a Phase 2 trial, which was initiated on August 1st 1999.

The most common disease conditions in clinical trials are Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell, and Gallbladder Neoplasms. The leading clinical trial sponsors are National Cancer Institute (NCI), M.D. Anderson Cancer Center, and University of Chicago.

Recent Clinical Trials for Dolastatin 10
Dolastatin 10 in Treating Patients With Advanced Kidney CancerNational Cancer Institute (NCI)Phase 2
Dolastatin 10 in Treating Patients With Advanced Kidney CancerMayo ClinicPhase 2
Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue SarcomaNational Cancer Institute (NCI)Phase 2

See all Dolastatin 10 clinical trials

Clinical Trial Summary for Dolastatin 10

Top disease conditions for Dolastatin 10
Top clinical trial sponsors for Dolastatin 10

See all Dolastatin 10 clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.